Stay updated on GARNET: Anti-PD-1 Antibody Clinical Trial
Sign up to get notified when there's something new on the GARNET: Anti-PD-1 Antibody Clinical Trial page.

Latest updates to the GARNET: Anti-PD-1 Antibody Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 removed; this is a minor site-version update that does not affect the study details or navigation.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check33 days agoChange DetectedAdded glossary toggle, new metadata entries (Last Update Submitted that Met QC Criteria, Last Update Posted), No FEAR Act Data, and a revision badge (Revision: v3.4.0). Removed older entries (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4).SummaryDifference0.1%

- Check40 days agoChange DetectedEnrollment updated to 730 and the study location count updated to 105. Multiple sites across Spain, South Korea, Mexico, Brazil, Argentina, and Poland were removed and location-related notes were revised.SummaryDifference4%

- Check69 days agoChange DetectedAdded a new Locations section listing trial sites across US states (e.g., Alabama, Arizona, California, District of Columbia, Florida, etc.) and Canadian provinces (Alberta, British Columbia, Ontario, Quebec) under revision v3.3.3; the previous revision’s location sections (v3.3.2) were removed.SummaryDifference1%

- Check90 days agoChange DetectedRevision from v3.3.1 to v3.3.2 is visible, unrelated to the study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to GARNET: Anti-PD-1 Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GARNET: Anti-PD-1 Antibody Clinical Trial page.